Inovan


Indications and Reactions:

Role Indications Reactions
Secondary
Heart Transplant 16.3%
Cardiac Failure 14.3%
Cardiac Failure Congestive 8.2%
Hypertension 8.2%
Pneumonia 8.2%
Pulmonary Hypertension 6.1%
Anticoagulant Therapy 4.1%
Hepatic Vein Occlusion 4.1%
Prophylaxis 4.1%
Prophylaxis Against Graft Versus Host Disease 4.1%
Sedation 4.1%
Anxiety 2.0%
Asthma 2.0%
Blood Pressure Decreased 2.0%
Chronic Obstructive Pulmonary Disease 2.0%
Congestive Cardiomyopathy 2.0%
Disseminated Intravascular Coagulation 2.0%
Hepatic Function Abnormal 2.0%
Hypotonia 2.0%
Parenteral Nutrition 2.0%
Subcutaneous Abscess 27.3%
Endotoxic Shock 18.2%
Atrial Flutter 9.1%
Nausea 9.1%
Necrosis 9.1%
Pneumothorax 9.1%
Right Ventricular Failure 9.1%
Systemic Inflammatory Response Syndrome 9.1%
Concomitant
Drug Use For Unknown Indication 26.6%
Prophylaxis 8.5%
Product Used For Unknown Indication 7.3%
Sedation 6.6%
Infection 5.4%
Fluid Replacement 5.2%
Cardiac Failure 5.0%
Ureteral Stent Insertion 3.9%
Ureteral Stent Removal 3.9%
Pneumonia 3.6%
Hypertension 3.5%
Infection Prophylaxis 3.3%
Insomnia 2.6%
Diuretic Therapy 2.4%
Mineral Supplementation 2.4%
Pyrexia 2.1%
Sepsis 2.0%
Ventricular Tachycardia 2.0%
Prophylaxis Against Graft Versus Host Disease 1.8%
Anticoagulant Therapy 1.7%
Multi-organ Failure 12.0%
Respiratory Failure 10.8%
White Blood Cell Count Increased 7.8%
White Blood Cell Count Decreased 7.2%
Renal Failure Acute 6.6%
Sepsis 6.0%
Septic Shock 6.0%
Renal Failure 4.8%
Cardiac Failure 4.2%
Pyrexia 4.2%
Blood Pressure Decreased 3.6%
Pneumonia 3.6%
Pulmonary Haemorrhage 3.6%
Urine Output Decreased 3.6%
Death 3.0%
Shock Haemorrhagic 3.0%
Ventricular Tachycardia 3.0%
Bundle Branch Block Left 2.4%
Delayed Recovery From Anaesthesia 2.4%
Drug Ineffective 2.4%

Drug Data